Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 04, 2015 9:46 AM ET


Company Overview of Xel Pharmaceuticals, Inc.

Company Overview

Xel Pharmaceuticals, Inc. develops proprietary drug delivery and extraction technologies and products. Its products include XEL 001HP, a Huperzine A transdermal patch for the treatment of Alzheimer's disease; and XEL 002BP, a Bulleyaconitine transdermal patch for pain management. Xel Pharmaceuticals, Inc. was formerly known as Xel Herbaceuticals, Inc. The company was founded in 1999 and is based in Draper, Utah.

12382 Gateway Park Place

Suite B800

Draper, UT 84020

United States

Founded in 1999





Key Executives for Xel Pharmaceuticals, Inc.

Co-Founder, Chief Executive Officer and President
Co-Founder and Chairman of the Board
Age: 64
Co-Founder and Chief Scientific Officer
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Sanofi-Aventis U.S. LLC United States
Eiger BioPharmaceuticals, Inc. United States
Bilcare Inc. United States
Amarin Pharmaceuticals, Inc. United States
Health Technology Resources Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Xel Pharmaceuticals, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at